Catheter Precision Inc. (VTAK) Stock Analysis

Catheter Precision Inc. (VTAK) is a publicly traded company in the HEALTHCARE sector. It trades at $0.98, carries a market capitalization of $2.48M. This page summarizes the public market data, fundamentals, and frequently asked questions for VTAK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

• Price: $0.98
• Market Cap: $2.48M
• EPS: $-10.48
• 52-Week High: $15.77
• 52-Week Low: $0.75

Market Sentiment

Catheter Precision Inc. currently has a Bullish sentiment score of 0.21.

About Catheter Precision Inc.

Catheter Precision, Inc. is a leading medical technology firm headquartered in Fort Mill, South Carolina, focused on advancing electrophysiology solutions aimed at improving the management and treatment of cardiac arrhythmias. The company is committed to enhancing clinical outcomes through its innovative products, which are specifically designed for patients, healthcare providers, and hospitals. By leveraging cutting-edge technology and a precision-driven approach, Catheter Precision stands a...

GNG Research Analysis

GNG Research scores Catheter Precision Inc. (VTAK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VTAK.

Frequently Asked Questions

Does VTAK pay dividends?

Catheter Precision Inc. (VTAK) does not currently pay a regular dividend.

What is VTAK's market cap?

Catheter Precision Inc. (VTAK) has a market capitalization of $2.48M with a current stock price of $0.98.